Tissue Factor Pathway Inhibitor Antagonists [MoA] - N0000194161
Pharmacologic Class Information
| Pharmacologic Code | N0000194161 |
| Pharmacologic Name | Tissue Factor Pathway Inhibitor Antagonists |
| Pharmacologic Uses |
|
| Pharmacologic Concept | Mechanisms of Action - [MoA] |
| Pharmacologic Concept Description | This concept refers to the mechanism of action pharmacologic action at the receptor, membrane, or tissue level. In MED-RT, molecular, subcellular, or cellular effects of drug generic ingredients, organized into a chemical function classification hierarchy, beneath the "Cellular or Molecular Interactions" concept. |
NDC Products with Tissue Factor Pathway Inhibitor Antagonists
The table contains 3 products whose active ingredient are classified under the same pharmacologic class Tissue Factor Pathway Inhibitor Antagonists [MoA].
| NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Company Name | Status | |
|---|---|---|---|---|---|---|---|
| 0169-2080 | Alhemo | Non-Proprietary Name: Concizumab | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
| 0169-2081 | Alhemo | Non-Proprietary Name: Concizumab | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE | |
| 0169-2084 | Alhemo | Non-Proprietary Name: Concizumab | Injection, Solution | Subcutaneous | Novo Nordisk | ACTIVE |
